p53 pathway
Li-Fraumeni syndrome (TP53)
RB pathway
Retinoblastoma syndrome (RB1)
Multiple endocrine neoplasia type 4 (CDKN1B)
CDKN2A-related tumor predisposition syndrome (CDKN2A)
CDK4-related melanoma predisposition syndrome (CDK4)
FAS pathway
Autoimmune lymphoproliferative syndrome (FAS)
Mismatch repair
Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)
Muir-Torre syndrome (MLH1, PMS2, MSHS2, MSH6)
Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)
Homologous recombination
BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)
PALB2-related cancer predisposition syndrome (PALB2)
RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)
Fanconi anemia (FANC genes)
Base excision repair genes
MUTYH-associated polyposis (MUTYH)
NTHL1-related tumor syndrome (NTHL1)
MBD4-associated neoplasia syndrome (MBD4)
Deficient nucleotide excision repair (NER) of DNA damage
Xeroderma Pigmentosum
Non-homologous end joining (NHEJ)
Ataxia-telangiectasia syndrome (ATM)
CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)
Nijmegen breakage syndrome (NBN)
DNA Polymerization
Polymerase proofreading-associated polyposis (POLD1, POLE)
Helicases
Bloom Syndrome (BLM)
Werner syndrome (WRN)
Rothmund-Thomson syndrome (ANAPC1, RECQL4)
DDX41-related hematologic tumor predisposition syndrome (DDX41)
Chromosomal non-dysjunction (aneuploidy) syndromes
Mosaic variegated aneuploidy (BUB1B, CEP57, TRIP13, BUB1, BUB3)
Klinefelter syndrome
Turner syndrome
Down syndrome
Imprinting disorders
Beckwith-Wiedemann spectrum (IGH2; CDKN1C)
Histone and DNA methylation
Enchondromatosis (IDH1, IDH2)
Chromatin remodelling pathway
Rhabdoid tumor predisposition syndrome (SMARCB1, SMARCA4)
Schwannomatosis (SMARCB1, LZTR1)
Clear cell meningioma predisposition syndrome (SMARCE1)
Weaver syndrome
Growth factor receptors
Hereditary papillary renal carcinoma (MET)
Multiple endocrine neoplastia type 2 (RET)
Juvenile polyposis syndrome (BMPR1A, SMAD4)
Hereditary neuroblastoma (ALK, PHOX2B)
Encephalocraniocutaneous lipomatosis (FGFR1)
G-coupled protein receptor pathway
Glucagon cell hyperplasia and neoplasia (GCGR)
McCune-Albright syndrome (GNAS)
Sturge-Weber syndrome (GNAQ)
RAS-MAPK pathway
Neurofibromatosis type 1 (NF1)
NF2-related schwannomatosis (NF2)
Costello syndrome (HRAS)
Noonan syndrome (Various genes)
Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)
PKA signalling pathway
Carney complex (PRKAR1A, PDE8B, PDE11A)
PROS syndrome (PIK3CA)
WNT/TGFbeta pathway
Familial adenomatous polyposis (APC)
Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)
AXIN2-associated polyposis (AXIN2)
Serrated polyposis (RNF43)
WT1 related tumor predisposition syndrome (WT1)
WAGR syndrome (WT1)
Multiple endocrine neoplasia type 1 (MEN1)
Peutz-Jeghers syndrome (STK11)
Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)
Hereditary mixed polyposis syndrome (GREM1)
Hedgehog signalling pathway
Nevoid basal cell carcinoma syndrome - Gorlin syndrome (PTCH1, SUFU, PGR161)
SMO-related Curry-Jones syndrome (SMO)
ELP1-related medulloblastoma predisposition syndrome (ELP1)
Osteochondromatosis (EXT1, EXT2)
NF-kB signalling pathway
Brooke-Spiegler syndrome (CYLD)
MTOR and PI3K pathway
Tuberous sclerosis (TSC1, TSC2)
PTEN hamartoma tumor syndrome (PTEN)
Activated Phosphatidylinositol-3-OH kinase Syndrome - APDS (PIK3CD)
Transcription factors and regulators
Multiple endocrine neoplasia type 5, MAX related tumors (MAX)
MAFA-related familial insulinomatosis (MAFA)
Birt-Hogg-Dube syndrome (FLCN)
Familial chordoma (TBXT)
Hyperparathyroidism jaw tumor syndrome (CDC73)
Angiogenesis
Von Hippel-Lindau syndrome
Krebs Cycle
SDH-deficient tumor syndrome- Hereditary pheochromocytoma-paraganglioma syndroms (SDHA, SDHB, SDHC, SDHD, SDHAF2)
Hereditary leiomyomatosis and renal cell carcinoma syndrome (FH)
Toxic metabolite-mediated disorders
Hereditary tyrosinemia type 1 (FAH)
Ubiquitin pathway
BAP1-related tumor predisposition syndrome (BAP1)
MicroRNA
DICER1-related tumor predisposition syndrome (DICER1)
MicroRNA processor tumor predisposition syndromes (DROSHA, DGCR8)
RNA splicing
Goldenhar syndrome (MYT1, SF3B2)
Telomere biology disorders
Dyskeratosis congenital (DKC1, TERT, TERC, TINF2, Other IBMFS genes)
POT1 and Shelterin-related tumor predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)